CheckMate 227 dual IO therapy nivo plus ipilimumab upfront for NSCLC

############################# Video Source: www.youtube.com/watch?v=Rrf_CDVKTdA

Solange Peters, MD, PhD, of University Hospital Vaudois, Lausanne, Switzerland, presents the CheckMate 227 trial final analysis (NCT02477826) at the European...

Speaker: Solange Peters, Event: ESMO 2019, Format: Press Brief, Subject: Lung Cancer, Subject: Non-Small Cell Lung Cancer, Field: Treatment, Field: Trial Updates, Field: Immuno-Oncology, Medicines: Nivolumab, Medicines: Ipilimumab, Medicines: Checkpoint Inhibitors, Trial: CheckMate 227, NCT02477826, late-breaking
#############################